Z-0171-2016 Class III Terminated

Recalled by Becton, Dickinson And Company, BD Biosciences — San Jose, CA

FDA device recall Z-0171-2016 was initiated by Becton, Dickinson And Company, BD Biosciences on Sep 30, 2015 and is designated Class III. Reason for recall: Two lots of CD3 (SK7) FITC label contains an error in the Spanish Small text. The recall status is terminated (terminated Oct 18, 2016). Affected quantity: 120 units.

Recall details

Product Type
Devices
Report Date
Nov 4, 2015
Initiation Date
Sep 30, 2015
Termination Date
Oct 18, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
120 units

Product description

BD CD3 (SK7) FITC; IVD; Catalog # 349201 and 340542 Hematology: The CD3 antibody reacts with the epsilon chain of the CD3 antigen/T-cell antigen receptor (TCR) complex. In vitro diagnostic.

Reason for recall

Two lots of CD3 (SK7) FITC label contains an error in the Spanish Small text.

Distribution pattern

US (nationwide) Distribution to the states of : TX, GA, IN, TN, CA, KY, WA, IL, MO, NY, CT, MN, NV, KS, WI, NH, FL, PA, OH, OR, SC. OK, NC and LA., and Internationally to Mexico.

Code information

Catalog Number: 349201; Lot Number 5148598 (expires 10-31-2016) Catalog Number: 340542; Lot Number 5113983 (expires 02-28-2017)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0171-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0171-2016. Report a data issue: hello@regdatalab.com.